Media Coverage

Our commercial intelligence and analysis are used by the Financial Times, the Wall Street Journal, Forbes, Nature, and Reuters, among others. Take a look at the latest Evaluate and Vantage coverage.

If you have questions about Evaluate or require data and expert insights to help support your editorial content, please see our Media Contacts.

Latest Media Coverage

Browse the archive

Pharmaceutical Executive

MassBio Releases 2018 Industry Snapshot

The Massachusetts Biotechnology Council (MassBio) released its 2018 Industry Snapshot report, in partnership with EvaluatePharma, which shows Massachusetts biotechs…


Perspectives on the week in pharma

GlaxoSmithKline is already working hard to convince the HIV world that its once-daily, two-pill regimen is as good as established triplet or quad treatments at keeping…


Look back at pharma news in week to August 10

The problem comes when reality catches up with the froth, as Australia’s Neuren Pharma found out last week, said EP Vantage, the editorial arm of the Evaluate…

Vantage logo
Kickstarting ideas
Independent, data-driven daily news and analysis on pharma, biotech and medtech.